Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
290 hedge funds and large institutions have $2.91B invested in Amedisys in 2024 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 105 increasing their positions, 82 reducing their positions, and 48 closing their positions.
28% more repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 82
13% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 48
1.87% more ownership
Funds ownership: 96.06% → 97.94% (+1.9%)
2% more funds holding
Funds holding: 285 → 290 (+5)
4% less capital invested
Capital invested by funds: $3.04B → $2.91B (-$124M)
23% less funds holding in top 10
Funds holding in top 10: 13 → 10 (-3)
80% less call options, than puts
Call options by funds: $72M | Put options by funds: $360M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAL
TIG Advisors LLC
New York
|
+$65.2M |
| 2 |
DKCM
Davidson Kempner Capital Management
New York
|
+$64M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$50.8M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$49.1M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$48.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
-$85.3M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$64.3M |
| 3 |
KLCMU
Kite Lake Capital Management (UK)
London,
United Kingdom
|
-$52M |
| 4 |
SGCM
Sand Grove Capital Management
London,
United Kingdom
|
-$32.8M |
| 5 |
Amundi
Paris,
France
|
-$27.1M |
AMED Hedge Fund Activity: Q4 2024 in Review
290 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2024, worth a combined $2.91B — down 4.1% from $3.04B a quarter earlier.
Buyers outnumbered sellers: 54 funds opened new AMED positions and 48 closed out — a net gain of 6 holders — while 105 added to existing stakes and 82 trimmed.
The largest buyer was TIG Advisors LLC, opening a new position worth an estimated $65.2M. The largest seller was Westchester Capital Management (New York), cutting an estimated $85.3M.
- 290 institutional investors held Amedisys (AMED) as of Q4 2024, up from 285 in Q3 2024.
- Funds reported $2.91B of Amedisys stock for Q4 2024, down 4.1% quarter-over-quarter.
- 54 funds opened new Amedisys positions in Q4 2024 and 48 closed out, a net change of +6 holders.
- The largest Amedisys buyer in Q4 2024 was TIG Advisors LLC, an estimated $65.2M added.
- The largest Amedisys seller in Q4 2024 was Westchester Capital Management (New York), an estimated $85.3M sold.
Based on aggregated 13F filings for Q4 2024.